Document Detail

Correction of anaemia and thrombocytopenia in a case of adult type I osteopetrosis with recombinant human erythropoietin (rHuEPO).
MedLine Citation:
PMID:  7772533     Owner:  NLM     Status:  MEDLINE    
A case of adult osteopetrosis Type I was diagnosed in a 22-year-old female. She presented for investigation of anaemia with 'myelophthisic' characteristics and extramedullary haemopoiesis which was resistant to haematinics, nandrolone and low-dose corticosteroids. She became progressively transfusion-dependent with gradually worsening thrombocytopenia. She was successfully treated with recombinant erythropoietin. Anaemia as well as thrombocytopenia were corrected. There appeared to be a synergistic action of erythropoietin with steroids.
J Meletis; M Samarkos; E Michali; S Vavourakis; C Meletis; C Poziopoulos; N Stavrogianni; K Konstantopoulos; G Vaiopoulos; X Yataganas
Related Documents :
10205993 - Hbothrace trait, hbothrace hemoglobinopathy and hbothrace/hb beta zero hemoglobinopathy...
15025373 - Aplastic anaemia following varicella infection with coexistent microfilaremia of wucher...
16416273 - Female hydrocele of the canal of nuck: a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  89     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  1995 Apr 
Date Detail:
Created Date:  1995-07-13     Completed Date:  1995-07-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  911-3     Citation Subset:  IM    
First Department of Internal Medicine,University of Athens School of Medicine, Laikon General Hospital, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / etiology,  therapy*
Bone Marrow Diseases / complications,  therapy
Erythropoietin / therapeutic use*
Osteopetrosis / therapy*
Recombinant Proteins / therapeutic use
Thrombocytopenia / etiology,  therapy*
Reg. No./Substance:
0/Recombinant Proteins; 11096-26-7/Erythropoietin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The incidence of factor VIII inhibitors in the United Kingdom, 1990-93. Inhibitor Working Party. Uni...
Next Document:  Long-term disease-free survival after autologous bone marrow transplantation in a primary plasma cel...